@ARTICLE{
author={Werth Victoria P,...,Radunovic Goran L,...,(broj koautora 18)},
year={2025},
title={Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary},
journal={IMMUNOTHERAPY},
volume={},
number={},
pages={-},
document_type={Editorial Material; Early Access},
} 

@ARTICLE{
author={Werth Victoria P,...,Radunovic Goran L,...,(broj koautora 19)},
year={2022},
title={Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus},
journal={NEW ENGLAND JOURNAL OF MEDICINE},
volume={387},
number={4},
pages={321-331},
document_type={Article},
} 

@ARTICLE{
author={Werth Victoria P,...,Radunovic Goran L,...,(broj koautora 17)},
year={2020},
title={BIIB059, a Humanized Monoclonal Antibody Targeting BDCA2 on Plasmacytoid Dendritic Cells (PDC), Shows Dose-Related Efficacy in the Phase 2 Lilac Study in Patients (PTS) with Active Cutaneous Lupus Erythematosus (CLE)},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={79},
number={},
pages={120-121},
document_type={Meeting Abstract},
}